Colloidal Bismuth Subcitrate 120 mg
Optimal First Line for Optimum Cure
Based on consensus and evidence it is best to achieve cure rates from the start.
Bismutum is highly effective in eradicating H. pylori bacteria, a key step in treating peptic ulcers.
Helps protect the stomach lining by reducing the depletion of gastric mucus, which can be damaged by H. pylori infection and other factors.
Contains antibacterial properties that directly target H. pylori, helping eliminate infection.
No reported cases of resistance to Bismutum, making it a reliable treatment option.
| Agent | Dosage | QID / BID |
|---|---|---|
| Colloidal Bismuth Subcitrate | 120 mg | QID |
| Metronidazole | 500 mg | TID |
| Tetracycline | 500 mg | QID |